<code id='C94BBB4D90'></code><style id='C94BBB4D90'></style>
    • <acronym id='C94BBB4D90'></acronym>
      <center id='C94BBB4D90'><center id='C94BBB4D90'><tfoot id='C94BBB4D90'></tfoot></center><abbr id='C94BBB4D90'><dir id='C94BBB4D90'><tfoot id='C94BBB4D90'></tfoot><noframes id='C94BBB4D90'>

    • <optgroup id='C94BBB4D90'><strike id='C94BBB4D90'><sup id='C94BBB4D90'></sup></strike><code id='C94BBB4D90'></code></optgroup>
        1. <b id='C94BBB4D90'><label id='C94BBB4D90'><select id='C94BBB4D90'><dt id='C94BBB4D90'><span id='C94BBB4D90'></span></dt></select></label></b><u id='C94BBB4D90'></u>
          <i id='C94BBB4D90'><strike id='C94BBB4D90'><tt id='C94BBB4D90'><pre id='C94BBB4D90'></pre></tt></strike></i>

          hotspot

          hotspot

          author:leisure time    Page View:518
          Sammy Kimball for STAT

          Is Wegovy really a brain drug? Which Alzheimer’s disease treatment works best? And what’s the point of Threads?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Megan Molteni joins us to explain the evolving science suggesting products like Wegovy are less weight loss drugs than treatments for human desire. We also explain why this summer is shaping up to be a pivotal moment for the treatment of Alzheimer’s and discuss our befuddlement with the latest social media platform.

          advertisement

          For more on what we cover, here’s the story on GLP-1 drugs and the brain; here’s the latest on Leqembi; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          Wikipedia

          Virginia high school admissions case could be legal follow
          Virginia high school admissions case could be legal follow

          3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

          read more
          The battle over 'scope creep' and who gets to be called 'doctor'
          The battle over 'scope creep' and who gets to be called 'doctor'

          StephanieW.EdmondsandGinnyL.Ryanarebothdoctors.Edmonds,aregisterednurse,hasaPh.D.;Ryanisatraditional

          read more
          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more

          Merck, Daiichi strike cancer drug pact worth up to $22 billion

          KenaBetancur/GettyImagesMADRID—MerckispayingbillionsofdollarstopartnerwithDaiichiSankyoonaseriesofca